| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 10/06/1993 | EP0563844A1 Antimicrobial compositions and pharmaceutical preparations thereof |
| 10/06/1993 | EP0563814A2 Carbonic acid esters of 2-amino-7-(1,3-dihydroxy-2-propoxymethyl)purines, their preparation and their use as antiviral agents |
| 10/06/1993 | EP0563734A1 9-fluoro-7-oxo-7H-pyrido(1,2,3-de)(1,4)benzoxazine carboxylic acids and esters and their use as antiviral agents |
| 10/06/1993 | EP0563733A1 Use of 7-oxo-7H-pyrido(1,2,3-de)(1,4)benzoxacin-6-carboxylic acid- and esters for the manufacture of a medicament for the treatment of viral diseases |
| 10/06/1993 | EP0563487A1 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferon |
| 10/06/1993 | EP0563485A1 In vitro generation of human dendritic cells and uses thereof |
| 10/06/1993 | EP0563475A1 Cell binding agent conjugates of derivatives of CC-1065 |
| 10/06/1993 | EP0563389A1 Pharmaceutical aerosol preparation and its use for treatment and prophylaxis of viral diseases |
| 10/06/1993 | EP0563311A1 Improved vaccines |
| 10/06/1993 | EP0563288A1 Immunopotentiation of vaccines, particularly swine pleuropneumonia vaccines |
| 10/06/1993 | EP0563240A1 Lipid receptors for microorganisms and corresponding adhesins, dna sequences encoding adhesins, and use thereof |
| 10/06/1993 | EP0563093A1 A composition used as a therapeutic agent against chronic viral hepatic diseases |
| 10/06/1993 | EP0563091A1 Vaccines based on hepatitis b surface antigen |
| 10/06/1993 | EP0379516B1 Hyper-immune globulin against hiv |
| 10/06/1993 | CN1076865A A novel process for preparing a vaccine for hemorrhagic fever with renal syndrome |
| 10/05/1993 | US5250678 For autoimmune, infectious diseases, organ transplant rejection; skin diseases, antiinflammatory agents |
| 10/05/1993 | US5250518 O-methyl derivatives of azithromycin A |
| 10/05/1993 | CA1322723C Inhibitors for replication of retroviruses and for the expression of oncogene products |
| 10/05/1993 | CA1322717C Combination of renal vasodilators and alpha 1-adrenergic or ganglionic blocking agents and methods for treating diseases |
| 10/05/1993 | CA1322713C Compositions and methods for modulating the effect of tnf and il-1 |
| 10/03/1993 | CA2093165A1 Formulated medicines and processed foods to potentiate host defense activity, and methods for treatment of infectious diseases |
| 10/03/1993 | CA2093108A1 9-fluoro-7-oxo-7h-pyrido[1,2,3-de][1,4]benzoxazine-6- carboxylic acids and esters |
| 10/03/1993 | CA2093106A1 Use of 7-oxo-7h-pyrido[1,2,3,-de][1,4]benzoxazine-6- carboxylic acids and esters as medicaments |
| 10/02/1993 | CA2093109A1 Morpholin- and thiomorpholin-4-ylamides |
| 10/02/1993 | CA2093099A1 Recombinant human hiv-neutralizing monoclonal antibodies for prevention and treatment of hiv infection |
| 09/30/1993 | WO1993019373A1 Broadly reactive opsonic antibodies that react with common staphylococcal antigens |
| 09/30/1993 | WO1993019183A1 Immunization by inoculatioon of dna transcription unit |
| 09/30/1993 | WO1993019179A1 Ifn receptors recognition factors, protein sequences and methods of use thereof |
| 09/30/1993 | WO1993019090A1 High molecular weight surface proteines of non-typeable haemophilus |
| 09/30/1993 | WO1993019075A1 Antiviral phosphonic acid derivatives of purine analogues |
| 09/30/1993 | WO1993019070A1 Carbapenem derivatives as antibiotics and intermediates thereof |
| 09/30/1993 | WO1993019061A1 Itraconazole and saperconazole stereoisomers |
| 09/30/1993 | WO1993019059A1 Antiviral peptides |
| 09/30/1993 | WO1993018791A1 Vaccine for preventing hiv-infected disease and production thereof |
| 09/30/1993 | WO1993018790A1 Vaccine containing live virus for therapy of viral diseases and malignancies |
| 09/30/1993 | WO1993018773A1 Novel aminosterol antibiotic |
| 09/30/1993 | WO1993018766A1 Further indole derivatives with antiviral activity |
| 09/30/1993 | WO1993018765A1 Indole derivatives with antiviral activity |
| 09/30/1993 | WO1993018654A1 Biological control of post-harvest diseases |
| 09/30/1993 | WO1993018650A1 Antiviral contraceptive devices, particularly condoms |
| 09/30/1993 | DE4307422A1 Verfahren zur Herstellung von Clavulansäuresalzen Process for the preparation of salts of clavulanic acid |
| 09/30/1993 | CA2132705A1 Biological control of post-harvest diseases |
| 09/30/1993 | CA2132317A1 Ifn receptors recognition factors, protein sequences and methods of use thereof |
| 09/30/1993 | CA2132303A1 Antiviral phosphonic acid derivatives of purine analogues |
| 09/30/1993 | CA2131615A1 Antiviral contraceptive devices, particularly condoms |
| 09/30/1993 | CA2131154A1 Antiviral peptides |
| 09/30/1993 | CA2130836A1 Further indole derivatives with antiviral activity |
| 09/29/1993 | EP0562855A1 Carbapenem compounds as antibiotics |
| 09/29/1993 | EP0562583A1 Alkylene diammonium diclavulanate derivatives, process for their preparation and for their use |
| 09/29/1993 | EP0562107A1 Oligoside derived from an antigen polyoside obtained from a pathogenic agent |
| 09/29/1993 | EP0562042A1 Quinoline, naphthyridine and pyridobenzoxazine derivatives |
| 09/29/1993 | EP0562013A1 Human retrovirus receptor and dna coding therefor |
| 09/29/1993 | EP0562009A1 ENANTIOMERICALLY PURE $g(b)-D-(-)-DIOXOLANE-NUCLEOSIDES |
| 09/29/1993 | EP0561912A1 Lectins in probiosis |
| 09/29/1993 | EP0561885A1 Subunit papillomavirus vaccine and peptides for use therein |
| 09/29/1993 | EP0561883A1 Polymorphs of crystalline mupirocin |
| 09/29/1993 | EP0561850A1 7-substituted-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid compounds useful as antibacterial agents |
| 09/29/1993 | EP0561827A1 Tetrapeptides deriving from dalbaheptide antibiotics. |
| 09/29/1993 | EP0428520B1 Antimicrobial composition with long-term activity |
| 09/29/1993 | EP0357709B1 Preservation of viruses |
| 09/29/1993 | CN1076689A N,n'-substituted imidodicarbonimidic diamides derived from hydroxylamines |
| 09/29/1993 | CN1076615A Low side-effect compound gentamicin preparation |
| 09/29/1993 | CN1022248C Novel 2'-halomethylidene, uridine and guanosine drivatives |
| 09/29/1993 | CA2092770A1 Carboxylic acid esters of 2-amino-7-/(1,3-dihydroxy-2-propoxy)methyl/purine, their preparation and their use |
| 09/28/1993 | US5248697 For treatment of radiation associated oxidative damage in tissue |
| 09/28/1993 | US5248693 Acetylene compounds and pharmaceutical compositions and methods of using the same |
| 09/28/1993 | US5248674 Percutaneous administration of 3'-azide'-deoxythymidine |
| 09/28/1993 | US5248670 Phosphorothioate internucleotide bonds |
| 09/28/1993 | US5248499 Control of microbial infections in transplant patients |
| 09/27/1993 | CA2091309A1 Antibiotic compounds |
| 09/23/1993 | EP0571524A4 Peroxyacid bleach precursor compositions. |
| 09/22/1993 | EP0561639A1 Cyclic peptide antifungal agents and process for preparation thereof |
| 09/22/1993 | EP0561525A1 Process for the expression of herpes simplex virus type 1 glycoprotein E and methods of use |
| 09/22/1993 | EP0561145A1 Use of a chemicallly stabilized chlorite matrix for the manufacture of medicaments for the treatment of HIV infections |
| 09/22/1993 | EP0561034A2 Direct molecular cloning of a modified eukaryotic cytoplasmic DNA virus genome |
| 09/22/1993 | EP0560969A1 Subunit vaccine for neisseria meningitidis infections and corresponding purified subunits |
| 09/21/1993 | US5246930 9-substituted compounds of 3α, 11α-epoxy-3,4,5,5aα,6,7,8,8a,9,11,11a-undecahydro-3β,6.alpha.,9-trimethylfurano[3,4-j][1,2]benzodioxepin, processes for their preparation and their use as antiprotozoal and antiviral agents |
| 09/21/1993 | US5246926 Cephalosporin derivatives |
| 09/21/1993 | US5246844 Detection of Lyme disease |
| 09/21/1993 | CA1322371C Carbapenem compound in crystalline form, and its production and use |
| 09/19/1993 | WO1993018763A1 Compositions of n-(phosphonoacetyl)-l-aspartic acid and methods of their use as broad spectrum antivirals |
| 09/19/1993 | CA2090303A1 Process for the expression of herpes simplex virus type 1 glycoprotein 1 and methods of use |
| 09/16/1993 | WO1993018150A1 Helicobacter pylori proteins useful for vaccines and diagnostics |
| 09/16/1993 | WO1993018056A1 Isosteric antiherpes peptide derivatives |
| 09/16/1993 | WO1993018055A2 Peptides stimulating cytotoxic lymphocytes respone to hiv-1 gp160 |
| 09/16/1993 | WO1993018054A2 Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them |
| 09/16/1993 | WO1993018050A1 Sugar derivatives of macrolides |
| 09/16/1993 | WO1993018049A1 Fluorosugar derivatives of macrolides |
| 09/16/1993 | WO1993018048A1 2-aminosugar derivatives of macrolides |
| 09/16/1993 | WO1993018044A1 Cephalosporin derivatives |
| 09/16/1993 | WO1993018042A1 Desosamino derivatives of macrolides as immunosuppressants and antifungal agents |
| 09/16/1993 | WO1993018040A1 Cyclic ketal derivatives |
| 09/16/1993 | WO1993018039A1 Cyclic ketal derivatives |
| 09/16/1993 | WO1993018024A1 1-alkoxy-2-(alkoxy- or cycloalkoxy)-4-(cyclo thioalkyl- or cyclothioalkenyl)benzenes as inhibitors of cyclic amp phosphodiesterase and tumour necrosis factor |
| 09/16/1993 | WO1993018009A1 Antiviral nucleoside analogues |
| 09/16/1993 | WO1993018006A1 Amine derivatives of oxo- and hydroxy-substitued hydrocarbons |
| 09/16/1993 | WO1993018003A1 Substitued pipecolinic acid derivatives as hiv protease inhibitors |
| 09/16/1993 | WO1993017717A1 Compositions and methods for modulating rna |
| 09/16/1993 | WO1993017712A2 Conjugates formed from heat shock proteins and oligo- or polysaccharides |
| 09/16/1993 | WO1993017706A1 Genetic vaccine for immunodeficiency viruses |